Résumé
Background: Anaesthetic requirements may be reduced following surgery employing cardiopulmonary bypass (CPB). This study, in dogs, determined the role of a) volatile agents (enflurane [E] vs isoflurane [I]), b) oxygenator (bubble [B] vs membrane [M]), and c) presence [FL] vs absence [NoFL] of an in-line arterial filter in the bypass circuit in altering anaesthetic requirements following CPB. Methods: Male mongrel dogs were anaesthetized with either enflurane (n = 24) or isoflurane (n = 24). They were randomly assigned to one of eight groups (n = 6 per group); Group 1 (E/B/FL), Group 2 (E/M/FL), Group 3 (E/M/NoFL), Group 4 (E/B/NoFL), Group 5 (I/M/FL), Group 6 (I/B/FL), Group 7 (I/M/NoFL) or Group 8 (I/B/NoFL). MAC was determined using the tail-clamp method at hourly intervals, twice before and three times after a one hour normothermic perfusion using aortoatrial cannulation and CPB. Results: Prior to CPB, MAC was reproducible (enflurane: MAC1 2.17 ± 0.29 vs MAC2 2.14 ± 0.28%; isoflurane: MAC1 1.42 ± 0.31 vs MAC2 1.41 ± 0.33%) and differed among groups only for the volatile agent employed. Following CPB, MAC was reduced in all groups (P < 0.05 vs pre-CPB measurements) except Group 1 (E/B/FL). The degree of MAC reduction in other groups ranged from 39-64% and was not different based on type of agent employed, use of a membrane or bubble oxygenator, or presence or absence of an in-line arterial filter. Conclusion: In dogs, MAC reduction following CPB was variable, not related to type of volatile agent employed, use of a membrane or bubble oxygenator, or presence or absence of an in-line arterial filter. The explanation for reductions in anaesthetic requirements following CPB in this model remains speculative.
Langue d'origine | English |
---|---|
Pages (de-à) | 1120-1126 |
Nombre de pages | 7 |
Journal | Canadian Journal of Anaesthesia |
Volume | 44 |
Numéro de publication | 10 |
DOI | |
Statut de publication | Published - oct. 1997 |
Note bibliographique
Funding Information:From the Departments of Anaesthesia,t Surgery," and Pharmacology,* Dalhousie University, Halifax, Nova Scotia, Canada. Supported by the Ncw Brunswick Heart and Stroke Foundation. Dr. Hall is a PMAC/MRC Health Research Foundation Scholar. Address correspondence to: Dr. Richard Hall, c/o Department of Anaesthesia, Queen Elizabeth II Health Sciences Centre, Halifax Infirmary Site, 1796 Summer Street, Halifax, Nova Scotia, Canada B3H 3A7. Presented, in part, at the LAPS 22rid Annual Congress, Orlando, Florida, March 1994. Accepted for publication July 1, 1997.
ASJC Scopus Subject Areas
- Anesthesiology and Pain Medicine